Lymphomatoid papulosis and associated lymphomas: A retrospective case series of 84 patients

Clinical and Experimental Dermatology

Volumn 34, Issue 5, 2009, Pages 576-581

  Kunishige, J H ^a   McDonald, H ^a   Alvarez, G ^a   Johnson, M ^a   Prieto, V ^a   Duvic, M ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; BETA 2 MICROGLOBULIN; BEXAROTENE; CD4 ANTIGEN; CD8 ANTIGEN; CHLORMETHINE; FLUCONAZOLE; IMIQUIMOD; LACTATE DEHYDROGENASE; METHOTREXATE; PSORALEN; PSORALEN ULTRAVIOLET A; RETINOID; STEROID; UNCLASSIFIED DRUG; VALACICLOVIR;

ADULT; ANAPLASTIC CARCINOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER PALLIATIVE THERAPY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RISK; CELL TRANSFORMATION; DISEASE ASSOCIATION; DISEASE SEVERITY; EPSTEIN BARR VIRUS; FEMALE; HERPES SIMPLEX; HERPES ZOSTER; HIGH RISK PATIENT; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHOMA; LYMPHOMATOID PAPULOSIS; MAJOR CLINICAL STUDY; MALE; MONONUCLEOSIS; MYCOSIS FUNGOIDES; PATIENT REFERRAL; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; T CELL LYMPHOMA; TREATMENT RESPONSE; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HUMANS; INFANT; LYMPHOMA, LARGE-CELL, ANAPLASTIC; LYMPHOMATOID PAPULOSIS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 66449135088     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2008.03024.x     Document Type: Article

References (20)

1. Macaulay WL. Lymphomatoid papulosis: a continuing self-healing eruption, clinically benign-histologically malignant. Arch Dermatol 1968 97 : 23 30.
2. Willemze R, Jaffe ES, Burg G et al. WHO-EORTC Classification for Cutaneous Lymphomas. Blood 2005 105 : 3768 85.
3. Willemze B, Beljaards RC. Spectrum of primary cutaneous CD30 (Ki-1) positive lymphoproliferative disorders. J Am Acad Dermatol 1993 28 : 973 80.
4. Cabanillas F, Armitage J, Pugh W et al. Lymphomatoid papulosis: a T-cell dyscrasia with a propensity to transform into malignant lymphoma. Ann Int Med 1995 122 : 210 17.
5. Wang HH, Myers T, Lach LJ et al. Increased risk of lymphoid and non-lymphoid malignancies in patients with lymphomatoid papulosis. Cancer 1999 86 : 1240 5.
6. Scheen RS, Doyle JA, Winklemann RK. Lymphoma-associated papulosis: lymphomatoid papulosis associated with lymphoma. J Am Acad Dermatol 1981 4 : 451 157.
7. El Shabrawi-Caelen L, Helmut K, Cerroni L. Lymphomatoid papulosis: reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C. Arch Dermatol 2004 140 : 441 7.
8. Durkop H, Latza U, Hummel M et al. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 1992 68 : 421 7.
9. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001 104 : 487 501. (Pubitemid 32201945)
10. Gruss HJ, Boiani N, Williams DE et al. Pleioropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 1994 83 : 2045 56.
11. Talpur R, Jones DM, Alencar AJ et al. CD25 expression is correlated with histological grade and response to denileukin difitox in cutaneous T-cell lymphoma. J Invest Dermatol 2006 126 : 575 83.
12. Liu L, Hoppe RT, Kohler S et al. CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. J Am Acad Dermatol 2003 49 : 1049 58.
13. Zackheim HS, Jones C, Leboid PE et al. Lymphomatoid papulosis associated with mycosis fungoides: a study of 21 patients including analysis for clonality. J Am Acad Dermatol 2004 50 : 202.
14. Wood GS. Analysis of clonality in cutaneous T-cell lymphomas and associated diseases. Ann N Y Acad Sci 2001 941 : 26 30.
15. Chott A, Vonderheid EC, Olbricht S et al. The dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis. J Invest Dermatol 1996 106 : 696 700. (Pubitemid 26119727)
16. Steinhoff M, Hummel M, Anagnostopoulos I et al. Single-cell analysis of CD30+ cells in lymphomatoid papulosis demonstrates common clonal T-cell origin. Blood 2002 100 : 578 84.
17. Gellrich S, Wernicke Sm Wilks A et al. The cell infiltrate in lymphomatoid papulosis comprises a mixture of polyclonal large atypical cells (CD30-positive) and smaller monoclonal T cells (CD30-negative). J Invest Dermatol 2004 122 : 859 61.
18. Kadin ME, Levi E, Kempf W. Progression of lymphomatoid papulosis to systemic lymphoma is associated with escape from growth inhibition by transforming growth factor-B and CD30 ligand. Ann N Y Acad Sci 2001 941 : 59 68. (Pubitemid 32928334)
19. Mori M, Manuelli C, Pimpinelli N et al. CD30-CD30 ligand interaction in primary cutaneous CD30+ T-cell lymphomas: a clue to the pathophysiology of clinical regression. Blood 1999 94 : 3077 83.
20. Granados S, Hwang ST. Roles for CD30 in the biology and treatment of CD30+ lymphoproliferative diseases. J Invest Dermatol 2004 122 : 1345 7.